Cadian Capital Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-107,561
Closed -$6.7M 36
2017
Q3
$6.7M Buy
107,561
+52,936
+97% +$3.3M 0.31% 37
2017
Q2
$4.35M Sell
54,625
-67,500
-55% -$5.38M 0.21% 38
2017
Q1
$8.68M Buy
+122,125
New +$8.68M 0.42% 37